---
title: "Epinephrine Bitartrate and Lidocaine Hydrochloride Injection Shortage: Availability Updates for Xylocaine"
summary: "The FDA reports a current shortage affecting specific presentations of Epinephrine Bitartrate and Lidocaine Hydrochloride Injection, with some supplies expected to return in February 2026."
category: "drug-shortages"
tags: ["drug-shortage","fda","medication","Epinephrine-Bitartrate","Lidocaine-Hydrochloride","Injection"]
location: "United States"
severity: "medium"
sourceUrl: "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
sourceAgency: "FDA"
publishedAt: 2026-02-11T19:12:10.000Z
---
### What's in Shortage

There is a current shortage of **Epinephrine Bitartrate and Lidocaine Hydrochloride Injection**, commonly known by the brand names **XYLOCAINE** and **XYLOCAINE MPF**. This medication is an injection used primarily in **Anesthesia** and **Pediatric** therapeutic categories. 

The shortage was first posted on October 14, 2016, and the most recent update was provided on February 5, 2026.

### Which Manufacturers Are Affected

**Fresenius Kabi USA, LLC** is the manufacturer currently reporting availability issues for specific presentations. While many versions remain available, several are currently backordered.

**Manufacturer Contact:** 888-386-1300

**Unavailable Presentations:**
*   Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17): Next release expected February 2026.
*   Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17): Next release expected February 2026.
*   Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17): Next release expected February 2026.

**Available Presentations:**
*   Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37)
*   Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37)
*   Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17)
*   Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57)
*   Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27)
*   Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27)
*   Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27)
*   Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57)
*   Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)

*Note: The manufacturer advises checking with wholesalers for current inventory.*

### Why There's a Shortage

The source data does not provide a specific reason for the current shortage of these presentations.

### What Patients Should Do

If you or a family member are scheduled for a procedure requiring this medication, please consider the following steps:
*   **Consult Your Healthcare Provider:** Discuss the availability of this medication with your doctor or surgeon. They can determine if an available presentation or an alternative treatment is appropriate for your care.
*   **Speak with Your Pharmacist:** Pharmacists often have the most up-to-date information regarding local stock and wholesaler availability.
*   **Contact the Manufacturer:** For specific questions regarding supply timelines, you may contact Fresenius Kabi USA, LLC at 888-386-1300.

*Disclaimer: Patients should always consult their healthcare provider regarding medication changes or treatment options.*

### Source

Information provided by the FDA Drug Shortage Database.